References:
  1. Galy-Bernadoy C, Garrel R. Head and neck soft-tissue sarcoma in adults. European annals of otorhinolaryngology, head and neck diseases. 2016 Feb 1;133(1):37-42.
  2. Thompson LDR, Franchi A. New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base. Virchows Arch. 2018 Mar;472(3):315-330.
  3. Lewis JT, Oliveira AM, Nascimento AG, Schembri-Wismayer D, Moore EA, Olsen KD, Garcia JG, Lonzo ML, Lewis JE. Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol. 2012 Apr;36(4):517-25. Doi: 10.1097/PAS.0b013e3182426886. PMID: 22301502.
  4. Stavrakas M, Nixon I, Andi K, Oakley R, Jeannon JP, Lyons A, McGurk M, Urbano TG, Thavaraj S, Simo R. Head and neck sarcomas: clinical and histopathological presentation, treatment modalities, and outcomes. J Laryngol Otol. 2016 Sep;130(9):850-9. Doi: 10.1017/S0022215116008604. Epub 2016 Aug 1. PMID: 27476336.
  5. Yamaguchi S, Nagasawa H, Suzuki T, Fujii E, Iwaki H, Takagi M, Amagasa T. Sarcomas of the oral and maxillofacial region: a review of 32 cases in 25 years. Clin Oral Investig. 2004 Jun;8(2):52-5. Doi: 10.1007/s00784-003-0233-4. PMID: 15281217.
  6. Gore MR. Treatment, outcomes, and demographics in sinonasal sarcoma: a systematic review of the literature. BMC Ear Nose Throat Disord. 2018 Mar 21;18:4. Doi: 10.1186/s12901-018-0052-5. PMID: 29581706; PMCID: PMC5861608.
  7. Mendenhall WM, Mendenhall CM, Werning JW, Riggs CE, Mendenhall NP. Sinonasal carcinoma. Head Neck. 2010;32(5):657-666. Doi: 10.1002/hed.21193.
  8. Piromchai P, Kasemsiri P, Thanaviratananich S. Sinonasal sarcoma: a systematic review. Int Forum Allergy Rhinol. 2016;6(6):657-663. Doi: 10.1002/alr.21746.
  9. Ramakrishnan VR, Suh JD, Chiu AG. Diagnosis and management of sinonasal tumors. Otolaryngol Clin North Am. 2011;44(5):1207-1226. Doi: 10.1016/j.otc.2011.06.013.
  10. Kuhar HN, Tajudeen BA, Mahajan A, et al. Sinonasal sarcoma: a comprehensive review of imaging, histopathology, and management. Int Forum Allergy Rhinol. 2017;7(1):74-79. Doi: 10.1002/alr.21846.
  11. Oikonomou A, Mouravas V, Petsas T, et al. The role of MRI in the preoperative staging of sinonasal sarcoma. Clin Radiol. 2020;75(5):396-406. Doi: 10.1016/j.crad.2019.12.009.
  12. Cho KJ, Cho SH, Kim JH, et al. Endoscopic features of sinonasal sarcoma. Clin Exp Otorhinolaryngol. 2015;8(1):80-84. Doi: 10.3342/ceo.2015.8.1.80.
  13. Bergamini G, O’Connell D, Vescovi P, et al. Fluorescence-guided endoscopic resection of sinonasal tumors. Eur Arch Otorhinolaryngol. 2016;273(2):381-387. Doi: 10.1007/s00405-015-3696-2.
  14. Lund VJ, Howard DJ, Harding L, Wei WI. Management options and survival in malignant tumors of the paranasal sinuses. Laryngoscope. 1991;101(4 Pt 1):349-353. Doi: 10.1288/00005537-199104000-00001.
  15. De Bree R, Haigentz Jr M, Silver CE, et al. Management of the neck in sinonasal cancer. Head Neck. 2016;38 Suppl 1:E244-252. Doi: 10.1002/hed.24099.
  16. Ghosh-Laskar S, Murthy V, Budrukkar A. Intensity-modulated radiation therapy in head and neck cancers: an overview. Mol Cancer. 2008;7:87. Doi: 10.1186/1476-4598-7-87.
  17. Patel TD, Vazquez A, Lustig RA, Ghosh A. Sinonasal sarcoma: prognostic factors, treatment, and survival. J Neurol Surg B Skull Base. 2016;77(6):523-528. Doi: 10.1055/s-0036-1571306.
  18. Niedźwiedzka-Rystwej P, Tokarz-Deptuła B, Deptuła W. Targeted therapies in head and neck cancer: a review of the current literature. Cancers (Basel). 2021;13(2):201. Doi: 10.3390/cancers13020201.